These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29970512)

  • 1. CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
    Schmid S; Csanadi A; Kozhuharov N; Tchudjin M; Kayser C; Rawluk J; Passlick B; Werner M; Prasse A; Kayser G
    Anticancer Res; 2018 Jul; 38(7):3913-3918. PubMed ID: 29970512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
    Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P
    Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Concentrations of CC-Chemokine-Ligand 18 Correlate with Tumor Size in Non-small Cell Lung Cancer and Are Elevated in Lymph Node-positive Disease.
    Schmid S; Le UT; Haager B; Mayer O; Dietrich I; Elze M; Kemna LJ; Zissel G; Passlick B
    Anticancer Res; 2016 Sep; 36(9):4667-71. PubMed ID: 27630310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial interaction and functional status of CD68
    Liu X; Zhang Z; Yuan J; Yu J; Chen D
    Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and significance of tumor associated macrophages and CXCR4 in non-small cell lung cancer.
    Yusen W; Xia W; Shengjun Y; Shaohui Z; Hongzhen Z
    J BUON; 2018; 23(2):398-402. PubMed ID: 29745083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer.
    Pei BX; Sun BS; Zhang ZF; Wang AL; Ren P
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1208-1216.e2. PubMed ID: 24907005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum level of CC chemokine ligand 18 correlates with the prognosis of non-small cell lung cancer.
    Huang H; Li J; Hu WJ; Chen C; Luo HQ; Tang XD; Zhou KY; Zhong WT; Li XY
    Int J Biol Markers; 2019 Jun; 34(2):156-162. PubMed ID: 31046524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer.
    Jackute J; Zemaitis M; Pranys D; Sitkauskiene B; Miliauskas S; Vaitkiene S; Sakalauskas R
    BMC Immunol; 2018 Jan; 19(1):3. PubMed ID: 29361917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
    Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
    Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
    Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
    Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
    Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage profile in primary versus secondary liver tumors.
    Avădănei ER; Wierzbicki PM; Giuşcă SE; Grigoraş A; Amălinei C; Căruntu ID
    Folia Histochem Cytobiol; 2014; 52(2):112-23. PubMed ID: 25007179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer.
    Zhang W; Pal SK; Liu X; Yang C; Allahabadi S; Bhanji S; Figlin RA; Yu H; Reckamp KL
    PLoS One; 2013; 8(5):e65121. PubMed ID: 23717691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Chung FT; Lee KY; Wang CW; Heh CC; Chan YF; Chen HW; Kuo CH; Feng PH; Lin TY; Wang CH; Chou CL; Chen HC; Lin SM; Kuo HP
    Int J Cancer; 2012 Aug; 131(3):E227-35. PubMed ID: 22174092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.